A prospective, multi-centre, randomised, open parallel group study to compare the effectiveness and compatibility of Arimidex (ZD1033) [anastrozole] with Nolvadex [tamoxifen] after a prior 2 years' treatment with tamoxifen in adjuvant therapy of breast carcinoma in postmenopausal women

Trial Profile

A prospective, multi-centre, randomised, open parallel group study to compare the effectiveness and compatibility of Arimidex (ZD1033) [anastrozole] with Nolvadex [tamoxifen] after a prior 2 years' treatment with tamoxifen in adjuvant therapy of breast carcinoma in postmenopausal women

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2009

At a glance

  • Drugs Anastrozole; Tamoxifen
  • Indications Early breast cancer; Menopause
  • Focus Therapeutic Use
  • Acronyms ARNO95
  • Sponsors AstraZeneca
  • Most Recent Events

    • 24 Jul 2006 Status change
    • 28 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top